GlaxoSmithKline PLC Indenture 2004 - change of trustee (4644D)
27 April 2017 - 2:25AM
UK Regulatory
TIDMGSK
RNS Number : 4644D
GlaxoSmithKline PLC
26 April 2017
GlaxoSmithKline plc
26 April 2017, London UK
NOTICE
To the Holders of
5.375% Notes due 2034 CUSIP # 377372 AB3
of GlaxoSmithKline Capital Inc.
NOTICE IS HEREBY GIVEN, pursuant to Section 8.08 of the
Indenture, dated as of April 6, 2004, as amended and supplemented
by the First Supplemental Indenture dated as of March 18, 2013 and
by the Second Supplemental Indenture dated as of March 21, 2014
(the "Indenture"), by and among GlaxoSmithKline Capital Inc.,
GlaxoSmithKline plc, as guarantor, and Law Debenture Trust Company
of New York, as Trustee, that Law Debenture Trust Company of New
York has resigned as trustee, registrar, paying agent and
authenticating agent under the Indenture.
Pursuant to Section 8.08 of the Indenture, Deutsche Bank Trust
Company Americas, a banking corporation duly organized and existing
under the laws of New York, has accepted appointment as trustee,
registrar, paying agent and authenticating agent under the
Indenture. The address of the designated corporate trust office of
the successor Trustee is 60 Wall Street, 16th Floor, New York, NY
10005.
Law Debenture Trust Company of New York's resignation as
trustee, registrar and paying agent and Deutsche Bank Trust Company
America's appointment as successor trustee, registrar, paying agent
and authenticating agent were effective as of the opening of
business on April 26, 2017.
Dated: April 26, 2017
GLAXOSMITHKLINE CAPITAL INC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEEFMMFWSEEL
(END) Dow Jones Newswires
April 26, 2017 12:25 ET (16:25 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024